279 related articles for article (PubMed ID: 9216807)
1. Molecular and epidemiological approaches to the etiology of urinary tract tumors in an area with Balkan endemic nephropathy.
Nikolov IG; Petkova-Bocharova D; Castegnaro M; Pfohl-Leskowicz A; Gill C; Day N; Chernozemsky IN
J Environ Pathol Toxicol Oncol; 1996; 15(2-4):201-7. PubMed ID: 9216807
[TBL] [Abstract][Full Text] [Related]
2. Balkan endemic nephropathy: role of ochratoxins A through biomarkers.
Castegnaro M; Canadas D; Vrabcheva T; Petkova-Bocharova T; Chernozemsky IN; Pfohl-Leszkowicz A
Mol Nutr Food Res; 2006 May; 50(6):519-29. PubMed ID: 16715544
[TBL] [Abstract][Full Text] [Related]
3. Ochratoxin A and other mycotoxins in cereals from an area of Balkan endemic nephropathy and urinary tract tumours in Bulgaria.
Petkova-Bocharova T; Castegnaro M; Michelon J; Maru V
IARC Sci Publ; 1991; (115):83-7. PubMed ID: 1820357
[TBL] [Abstract][Full Text] [Related]
4. Are mycotoxins risk factors for endemic nephropathy and associated urothelial cancers?
Castegnaro M; Chernozemsky IN; Hietanen E; Bartsch H
Arch Geschwulstforsch; 1990; 60(4):295-303. PubMed ID: 2202269
[TBL] [Abstract][Full Text] [Related]
5. Ochratoxin A in human blood in relation to Balkan endemic nephropathy and urinary tract tumours in Bulgaria.
Petkova-Bocharova T; Castegnaro M
IARC Sci Publ; 1991; (115):135-7. PubMed ID: 1820326
[TBL] [Abstract][Full Text] [Related]
6. Urinary tract tumors and Balkan nephropathy in the South Morava River basin.
Cukuranović R; Ignjatović M; Stefanović V
Kidney Int Suppl; 1991 Nov; 34():S80-4. PubMed ID: 1762341
[TBL] [Abstract][Full Text] [Related]
7. Ochratoxin A concentrations in food and feed from a region with Balkan Endemic Nephropathy.
Abouzied MM; Horvath AD; Podlesny PM; Regina NP; Metodiev VD; Kamenova-Tozeva RM; Niagolova ND; Stein AD; Petropoulos EA; Ganev VS
Food Addit Contam; 2002 Aug; 19(8):755-64. PubMed ID: 12227939
[TBL] [Abstract][Full Text] [Related]
8. New molecular and field evidences for the implication of mycotoxins but not aristolochic acid in human nephropathy and urinary tract tumor.
Pfohl-Leszkowicz A; Tozlovanu M; Manderville R; Peraica M; Castegnaro M; Stefanovic V
Mol Nutr Food Res; 2007 Sep; 51(9):1131-46. PubMed ID: 17729220
[TBL] [Abstract][Full Text] [Related]
9. Balkan endemic nephropathy and associated urinary tract tumours: a review on aetiological causes and the potential role of mycotoxins.
Pfohl-Leszkowicz A; Petkova-Bocharova T; Chernozemsky IN; Castegnaro M
Food Addit Contam; 2002 Mar; 19(3):282-302. PubMed ID: 11834078
[TBL] [Abstract][Full Text] [Related]
10. The role of ochratoxin A as a possible cause of Balkan endemic nephropathy and its risk evaluation.
Stoev SD
Vet Hum Toxicol; 1998 Dec; 40(6):352-60. PubMed ID: 9830698
[TBL] [Abstract][Full Text] [Related]
11. Analysis of ochratoxin A in foods consumed by inhabitants from an area with balkan endemic nephropathy: a 1 month follow-up study.
Vrabcheva T; Petkova-Bocharova T; Grosso F; Nikolov I; Chernozemsky IN; Castegnaro M; Dragacci S
J Agric Food Chem; 2004 Apr; 52(8):2404-10. PubMed ID: 15080654
[TBL] [Abstract][Full Text] [Related]
12. Ochratoxin A in human kidney diseases.
Fuchs R; Peraica M
Food Addit Contam; 2005; 22 Suppl 1():53-7. PubMed ID: 16332622
[TBL] [Abstract][Full Text] [Related]
13. Genetic predisposition to Balkan endemic nephropathy: ability to hydroxylate debrisoquine as a host risk factor.
Nikolov IG; Chernozemsky IN; Idle JR
IARC Sci Publ; 1991; (115):289-96. PubMed ID: 1820343
[TBL] [Abstract][Full Text] [Related]
14. [Ochratoxin A genotoxicity, relation to renal tumors].
Maaroufi K; Pfohl-Leszkowicz A; Achour A; el May M; Grosse Y; Hammami M; Ellouz F; Creppy EE; Bacha H
Arch Inst Pasteur Tunis; 1994; 71(1-2):21-31. PubMed ID: 7661650
[TBL] [Abstract][Full Text] [Related]
15. Ochratoxin A-related DNA adducts in urinary tract tumours of Bulgarian subjects.
Pfohl-Leszkowicz A; Grosse Y; Castegnaro M; Nicolov IG; Chernozemsky IN; Bartsch H; Betbeder AM; Creppy EE; Dirheimer G
IARC Sci Publ; 1993; (124):141-8. PubMed ID: 8225477
[TBL] [Abstract][Full Text] [Related]
16. Epidemiological aspects of Balkan endemic nephropathy in a typical focus in Yugoslavia.
Ceović S; Plestina R; Miletić-Medved M; Stavljenić A; Mitar J; Vukelić M
IARC Sci Publ; 1991; (115):5-10. PubMed ID: 1820354
[TBL] [Abstract][Full Text] [Related]
17. Balkan endemic nephropathy and papillary transitional cell tumors of the renal pelvis and ureters.
Petronić VJ; Bukurov NS; Djokić MR; Milenković DZ; Vuksanović AM; Avramović AD; Nale DP
Kidney Int Suppl; 1991 Nov; 34():S77-9. PubMed ID: 1762340
[TBL] [Abstract][Full Text] [Related]
18. Ochratoxin A as a potential etiologic factor in endemic nephropathy: lessons from toxicity studies in rats.
Mally A; Hard GC; Dekant W
Food Chem Toxicol; 2007 Nov; 45(11):2254-60. PubMed ID: 17629386
[TBL] [Abstract][Full Text] [Related]
19. Concentrations of ochratoxin A in the urine of endemic nephropathy patients and controls in Bulgaria: lack of detection of 4-hydroxyochratoxin A.
Castegnaro M; Maru V; Petkova-Bocharova T; Nikolov I; Bartsch H
IARC Sci Publ; 1991; (115):165-9. PubMed ID: 1820331
[TBL] [Abstract][Full Text] [Related]
20. Fifty years of research in Balkan endemic nephropathy: where are we now?
Stefanović V; Polenaković M
Nephron Clin Pract; 2009; 112(2):c51-6. PubMed ID: 19390202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
